Xcout Intel
Nuritas
Nuritas uses a proprietary AI platform to discover, validate, and supply natural peptide ingredients for oral and topical health and wellness formulations. The company serves health and wellness brands by providing clinically-backed ingredients and custom peptide discovery services.
Subscribe to see Nuritas’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nuritas at a glance
Nuritas is a biotech company headquartered in Ireland. Xcout tracks 9 named people at Nuritas, including Conor Walshe (Chief Financial Officer). Xcout recorded 1 job posting from Nuritas in the last 90 days.
Nuritas leadership
- Conor WalsheChief Financial Officer
- Alison AndersonChief People Officer
- John CaseyChief Manufacturing & Supply Chain Officer
- Dr. Nora KhaldiFounder & CEO
- Alex SeddonM&G Investments Head of Impact & Private Equity
- Dr. Alan BartonChairman
3 more named people on record for Nuritas, with roles, board committees and tenure — see the full roster →
Hiring at Nuritas
Xcout recorded 1 job posting from Nuritas in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Nuritas's hiring signals →
Recent Nuritas news
Nuritas competitors
A few of Nuritas's closest competitors — see the full list of competitors and alternatives →
Genvor Inc utilizes an AI-accelerated peptide platform to develop sustainable agricultural solutions and human health wellness products. The company serves agricultural partners through licensing and co-development to improve crop protection, stress tolerance, and yields, while also providing targeted peptide products for consumer recovery, performance, anti-aging, and daily wellness.
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Peptilogics, Inc. is a biotechnology company founded in 2013 and headquartered in Pittsburgh, Pennsylvania. The company utilizes advanced computational and biological approaches to discover and develop novel peptide therapeutics.
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Get Nuritas's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nuritas in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access